Digital medical care is upgraded again to promote the full online management of diabetic patients

With the continuous deepening of my country's medical system reform, the patient experience of seeking medical care has improved, but it is still far from the patient's requirements for the selectivity and convenience of medical care.
The emergence of new disease diagnosis and management models such as Internet hospitals, telemedicine, and online follow-up diagnosis has further expanded the choice of medical services and improved convenience.
In 2015, the State Council issued a number of documents such as the "Healthy China 2030" Planning Outline" and the "Guiding Opinions of the State Council on Actively Promoting the "Internet +" Action" and other documents to support online follow-up visits for common and chronic diseases.
The development model provides guidance.
As a common chronic disease, diabetes mellitus has a high frequency of medical treatment and difficult offline management.
Through online and offline linkages, Internet medical care can optimize the experience of patients with diabetes, improve the efficiency of diagnosis and treatment, and play a role in controlling and alleviating the progression of disease.
On June 1, 2021, Sanofi China and JD Health jointly announced that the two parties will work together again to carry out strategic cooperation upgrades in the field of health digital ecology, and create digital comprehensive solutions around the entire process of online diagnosis and treatment of patients throughout the life cycle.

Committed to promoting the standardized development of the "Internet + medical and health" industry.
Through this upgraded cooperation, the two parties will use their respective advantages to initiate a comprehensive strategic cooperation in the five areas of prescription drugs, vaccines, consumer health products, medical services, and commercial insurance, and explore innovative payment methods to improve patients’ Internet access to medical care in an all-round way.

With the continuous deepening of my country's medical system reform, the patient experience of seeking medical care has improved, but it is still far from the patient's requirements for the selectivity and convenience of medical care.

"As one of the world's first multinational companies to adopt digital technology to improve the prognosis of patients, Sanofi makes full use of its rich experience and resources in chronic disease management, actively explores Internet hospital business innovation models, and provides patients with integrated solutions.
" Philippine Greater China President Dr.
Pius S.
Hornstein (PhD) said, “In order to cooperate with the digital China blueprint in the 14th Five-Year Plan, Sanofi China, as one of the industry pioneers, is working hard to accelerate its own digital transformation.
We will make full use of various digital innovations to improve patient prognosis, and we are committed to building a higher-level digital medical ecosystem.
" At present, the burden of chronic diseases in the country is becoming heavier, and chronic diseases have become a major public health problem affecting China’s economic and social development.
.
Studies have shown that chronic diseases are the most important cause of death for Chinese residents, with deaths constituting more than 80%, and per capita medical expenses generally exceed 40% of household income.
As an innovative solution to chronic diseases, Internet healthcare is still facing many challenges while it is developing vigorously.
For example, on some platforms, when patients conduct online consultations, they do not have high professional trust in doctors, doctors respond slowly, and the answers are modular and lack specificity, which affects the consultation experience of patients at both ends of the doctor and the patient; while online In terms of drug purchase, there are problems such as non-coverage of medical insurance, patients' concerns about the quality of drugs, and the safety of drug transportation, which further reduces the patient's sense of acquisition and compliance with online consultation.
After Sanofi became an in-depth partner of JD Health Diabetes Center last year, Sanofi and JD Health once again joined forces to promote the standardization of Internet online diagnosis and treatment, and create a new ecology of benign and sustainable development of digital health care.
Xin Lijun, Senior Vice President of JD Group and CEO of JD Health, said: "JD Health has used artificial intelligence, big data, Internet of Things and other digital technologies in the past few years to combine services such as online consultation, renewal of prescription purchases and home delivery of medicines.
, Built an online and offline integrated management model to provide patients with efficient and professional management services.
As an integrated open platform, we hope to introduce different chronic disease management service capabilities to provide patients with a diversified service experience.
At this point , JD Health and Sanofi can have a very good combination.
Both parties can gather superior resources to jointly promote the establishment of integrated prevention, diagnosis, treatment, rehabilitation and follow-up solutions, and promote the standardized development of the Internet medical and health industry.
"Facing the future of the digital transformation of the health industry, digital marketing has become a prairie fire, and it has become an indispensable method for pharmaceutical companies.
I believe that in the near future, the conceptual boundaries of digital marketing will continue to break through, and brand-new models and technologies will emerge.


Leave a message here